Shamardl, H., Sadek, S., & Ahmed, A. (2023). Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats. Fayoum University Medical Journal, 12(2), 84-94. doi: 10.21608/fumj.2023.323618
MLA
Hanan Shamardl; Sawsan Sadek; Amany Ahmed. "Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats". Fayoum University Medical Journal, 12, 2, 2023, 84-94. doi: 10.21608/fumj.2023.323618
HARVARD
Shamardl, H., Sadek, S., Ahmed, A. (2023). 'Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats', Fayoum University Medical Journal, 12(2), pp. 84-94. doi: 10.21608/fumj.2023.323618
VANCOUVER
Shamardl, H., Sadek, S., Ahmed, A. Assessment of SGLT2 Inhibitor, Canagliflozin Effects on Metabolic Syndrome-Induced Cardiovascular Disorders in Rats. Fayoum University Medical Journal, 2023; 12(2): 84-94. doi: 10.21608/fumj.2023.323618